Skip to main content

News

News
03/27/2024
Almost 380,000 vials of nicardipine hydrochloride injection distributed by AuroMedics Pharma are being recalled for organic impurities.
Almost 380,000 vials of nicardipine hydrochloride injection distributed by AuroMedics Pharma are being recalled for organic impurities.
Almost 380,000 vials of...
03/27/2024
Pharmacy Learning Network
News
03/21/2024
Failures in stability testing for active pharmaceutical ingredients prompted the recall of 9831 bottles of Broncochem Kids Cold & Flu Syrup and 2345 boxes of Broncochem Cold & Flu Tea.
Failures in stability testing for active pharmaceutical ingredients prompted the recall of 9831 bottles of Broncochem Kids Cold & Flu Syrup and 2345 boxes of Broncochem Cold & Flu Tea.
Failures in stability testing...
03/21/2024
Pharmacy Learning Network
News
03/21/2024
Nearly 120,000 bottles of telmisartan tablets distributed in Tennessee, Rhode Island, and Puerto Rico are under recall for being out of specification for blend uniformity.
Nearly 120,000 bottles of telmisartan tablets distributed in Tennessee, Rhode Island, and Puerto Rico are under recall for being out of specification for blend uniformity.
Nearly 120,000 bottles of...
03/21/2024
Pharmacy Learning Network
News
03/21/2024
McKesson Medical-Surgical Inc. is recalling a trio of injections it distributed in New Mexico, Arizona, and Utah because the products were not stored according to drug label specifications.
McKesson Medical-Surgical Inc. is recalling a trio of injections it distributed in New Mexico, Arizona, and Utah because the products were not stored according to drug label specifications.
McKesson Medical-Surgical Inc....
03/21/2024
Pharmacy Learning Network
News
03/20/2024
A harm reduction approach to substance use provides realistic support for patients who are hospitalized for other medical reasons, according to a Psychiatric News article.
A harm reduction approach to substance use provides realistic support for patients who are hospitalized for other medical reasons, according to a Psychiatric News article.
A harm reduction approach to...
03/20/2024
Pharmacy Learning Network
News
03/18/2024

By Emry Lloyd

By Emry Lloyd
Patients are gaining back the weight they lost after discontinuing Ozempic. Experts do not recommend lifelong Ozempic use, and side effects highlighting discontinuation for patients struggling with weight loss.
Patients are gaining back the weight they lost after discontinuing Ozempic. Experts do not recommend lifelong Ozempic use, and side effects highlighting discontinuation for patients struggling with weight loss.
Patients are gaining back the...
03/18/2024
Pharmacy Learning Network
News
03/18/2024
The US Food and Drug Administration (FDA) recently approved Xolair (omalizumab) for the reduction of allergic reactions, including anaphylaxis, after accidental exposure to one or more foods in adults and children 1 year and older with...
The US Food and Drug Administration (FDA) recently approved Xolair (omalizumab) for the reduction of allergic reactions, including anaphylaxis, after accidental exposure to one or more foods in adults and children 1 year and older with...
The US Food and Drug...
03/18/2024
Pharmacy Learning Network
News
03/14/2024
From 2016 to 2022, there has been an increase in dispensing antidepressants to adolescents and young adults. However, the rate of increase was 63.5% faster after the COVID-19 outbreak, according to a study published in Pediatrics.
From 2016 to 2022, there has been an increase in dispensing antidepressants to adolescents and young adults. However, the rate of increase was 63.5% faster after the COVID-19 outbreak, according to a study published in Pediatrics.
From 2016 to 2022, there has...
03/14/2024
Pharmacy Learning Network
News
03/13/2024
Eugia US is recalling 10,080 vials of methylprednisolone acetate injectable suspension for failing to meet dissolution specifications.
Eugia US is recalling 10,080 vials of methylprednisolone acetate injectable suspension for failing to meet dissolution specifications.
Eugia US is recalling 10,080...
03/13/2024
Pharmacy Learning Network
News
03/13/2024
Defective containers have prompted Contract Pharmaceuticals Limited Canada to recall more than 57,000 bottles of clindamycin phosphate topical solution.
Defective containers have prompted Contract Pharmaceuticals Limited Canada to recall more than 57,000 bottles of clindamycin phosphate topical solution.
Defective containers have...
03/13/2024
Pharmacy Learning Network